Literature DB >> 16765139

Drug-induced liver injury: Hy's rule revisited.

Einar Björnsson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16765139     DOI： 10.1016/j.clpt.2006.02.012

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  31 in total

Review 1.  Mechanisms of drug toxicity and relevance to pharmaceutical development.

Authors:  F Peter Guengerich
Journal:  Drug Metab Pharmacokinet       Date:  2010-10-22       Impact factor: 3.614

Review 2.  Idiosyncratic drug-induced liver injury: a clinical update.

Authors:  Haripriya Maddur; Naga Chalasani
Journal:  Curr Gastroenterol Rep       Date:  2011-02

3.  Profiling cumulative proportional reporting ratios of drug-induced liver injury in the FDA Adverse Event Reporting System (FAERS) database.

Authors:  Allen D Brinker; Jenna Lyndly; Joseph Tonning; David Moeny; Jonathan G Levine; Mark I Avigan
Journal:  Drug Saf       Date:  2013-12       Impact factor: 5.606

Review 4.  In vitro platforms for evaluating liver toxicity.

Authors:  Shyam Sundhar Bale; Lawrence Vernetti; Nina Senutovitch; Rohit Jindal; Manjunath Hegde; Albert Gough; William J McCarty; Ahmet Bakan; Abhinav Bhushan; Tong Ying Shun; Inna Golberg; Richard DeBiasio; Berk Osman Usta; D Lansing Taylor; Martin L Yarmush
Journal:  Exp Biol Med (Maywood)       Date:  2014-04-24

5.  Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA.

Authors:  Ruud S Kootte; Loek P Smits; Fleur M van der Valk; Jean-Louis Dasseux; Constance H Keyserling; Ronald Barbaras; John F Paolini; Raul D Santos; Theo H van Dijk; Geesje M Dallinga-van Thie; Aart J Nederveen; Willem J M Mulder; G Kees Hovingh; John J P Kastelein; Albert K Groen; Erik S Stroes
Journal:  J Lipid Res       Date:  2015-01-05       Impact factor: 5.922

6.  Long-term coculture strategies for primary hepatocytes and liver sinusoidal endothelial cells.

Authors:  Shyam Sundhar Bale; Inna Golberg; Rohit Jindal; William J McCarty; Martha Luitje; Manjunath Hegde; Abhinav Bhushan; Osman Berk Usta; Martin L Yarmush
Journal:  Tissue Eng Part C Methods       Date:  2014-11-06       Impact factor: 3.056

7.  Predicting drug-induced liver injury in human with Naïve Bayes classifier approach.

Authors:  Hui Zhang; Lan Ding; Yi Zou; Shui-Qing Hu; Hai-Guo Huang; Wei-Bao Kong; Ji Zhang
Journal:  J Comput Aided Mol Des       Date:  2016-09-17       Impact factor: 3.686

8.  Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial.

Authors:  Robert J Motzer; Camillo Porta; Nicholas J Vogelzang; Cora N Sternberg; Cezary Szczylik; Jakub Zolnierek; Christian Kollmannsberger; Sun Young Rha; Georg A Bjarnason; Bohuslav Melichar; Ugo De Giorgi; Viktor Grünwald; Ian D Davis; Jae-Lyun Lee; Emilio Esteban; Gladys Urbanowitz; Can Cai; Matthew Squires; Mahtab Marker; Michael M Shi; Bernard Escudier
Journal:  Lancet Oncol       Date:  2014-02-17       Impact factor: 41.316

9.  Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.

Authors:  Naga Chalasani; Robert J Fontana; Herbert L Bonkovsky; Paul B Watkins; Timothy Davern; Jose Serrano; Hongqiu Yang; James Rochon
Journal:  Gastroenterology       Date:  2008-09-17       Impact factor: 22.682

Review 10.  Current concepts of mechanisms in drug-induced hepatotoxicity.

Authors:  Stefan Russmann; Gerd A Kullak-Ublick; Ignazio Grattagliano
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.